Navigation Links
Many Patients Stop Taking Cholesterol-Lowering Drugs
Date:11/7/2007

Cost, language barriers often to blame, study finds

WEDNESDAY, Nov. 7 (HealthDay News) -- Even though cholesterol-lowering statin drugs are known to be effective, many patients stop taking them, and researchers say a number of factors may be to blame.

In their study, researchers in Chicago analyzed a large pharmacy's database.

They found that statin discontinuation rates among more than 768,000 patients were 28 percent after three months, 41 percent after six months, and 59 percent after one year.

"We found that subjects who were on high-dose statins, paid high co-payments, or spoke Spanish were significantly more likely to discontinue," said the investigators at Radiant Research Inc.

Patients who used the Internet, had heart disease or high blood pressure were significantly less likely to stop taking statins.

Taking steps to address problems such as side effects associated with high doses of statins, high co-payments, and language issues may help improve patients' long-term statin therapy compliance, the researchers suggested.

The study was to be presented Thursday at the American Heart Association's annual meeting, in Orlando, Fla.

A second study to be presented at the same meeting found that, among American hypertension patients with increased risk of coronary artery disease, the time it took to bring "bad" low density lipoprotein (LDL) cholesterol under control was much longer for all women and black men than for non-black men.

These disparities in risk reduction can likely be attributed to patient differences in access/adherence to lipid-lowering medication therapy, said the University of Pennsylvania researchers.

More information

The American Academy of Family Physicians has more about cholesterol-lowering medications.



-- Robert Preidt



SOURCE: Nov. 7, 2007, presentations, American Heart Association annual meeting, Orlando, Fla.


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
2. Comparison of obstetric outcomes between on-call and patients own obstetricians
3. Vision restoration therapy shown to improve brain activity in brain injured patients
4. Diabetes appears to increase risk of death for patients with acute coronary syndromes
5. Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia
6. Restricting Blood Flow May Help Heart Bypass Patients
7. Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer
8. Study provides hope that some transplant patients could live free of antirejection drugs
9. Study provides hope that some transplant patients could live free of anti-rejection drugs
10. Longer ambulance journeys boost death risk for seriously ill patients
11. Expenses Overshadow Optimism for Kidney Failure Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... ... CloudLIMS, joins an elite number of companies that have earned a spot on ... CIOReview. , In a deliberate session with the honorary industrial experts, a list of ... with. The positioning is based on evaluation of CloudLIMS’ specialties in Automated Sample Management ...
(Date:5/25/2016)... ... 25, 2016 , ... DKT International, one of the largest ... pleased to release their 2015 global impact data. In 2015, DKT served over ... deaths and 3.8 million unsafe abortions across 21 countries worldwide. , “We ...
(Date:5/25/2016)... Mexico (PRWEB) , ... May 25, 2016 , ... Casa ... the restorative properties of precious stones to complement its new wellness suites . ... two floors and feature a plethora of special services and insuite amenities, from a ...
(Date:5/25/2016)... ... ... more than fifty years, we've suffered whiplash as each new scientific study seemed to contradict ... nutritional advice – advice that was supposed to keep us healthy and slim. And what ... are considered to be overweight and more than 1 in 3 adults are considered to ...
(Date:5/25/2016)... ... 25, 2016 , ... Researchers from SUNY State College of Optometry won the ... visual evoked potential and human attention. The article, VEP and Human Attention: Translation ... ERG and VEP Vision Testing System (Diopsys, Inc., Pine Brook, NJ) to record ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)...   , Study met both ... in , Excellent plus Good ... of the ascending colon   ,      ... announced new positive data from the phase III MORA study for ... litre PEG with ascorbate. The study met both primary endpoints showing ...
(Date:5/24/2016)... 2016 ARANZ Medical  Ltd a ... sector, has been named the Coretex Hi-Tech Emerging Company of ... Dr Bruce Davey , CEO of ARANZ Medical ... really good to be recognised for the work we are ... used in 35 countries around the world from Sub-Saharan Africa ...
(Date:5/24/2016)... 2016 Celsion Corporation (NASDAQ: ... provided an update on its ongoing OVATION study, ... GEN-1, the Company,s DNA-based immunotherapy, with the standard ... with advanced ovarian cancer who will undergo neoadjuvant ... an IL-12 DNA plasmid vector formulated as a ...
Breaking Medicine Technology: